Sumera Qureshi
Impact in
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
-
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Rheumatoid Arthritis Research and Therapies 4
-
- Forensic Toxicology and Drug Analysis 1
- Co-authors
- Sam Norton (2 shared papers)Maryam A. Adas (2 shared papers)Andrew P. Cope (2 shared papers)James Benjamin Galloway (2 shared papers)Katie Bechman (2 shared papers)Sanketh Rampes (1 shared paper)Mark Yates (1 shared paper)Amir Mehrkar (1 shared paper)
- Journals
- The Lancet Rheumatology (2 papers)Autoimmunity Reviews (1 paper)Arthritis & Rheumatology (1 paper)RMD Open (1 paper)The Lancet (1 paper)
- Partner nations
- United KingdomPakistanIndia
In The Last Decade
Sumera Qureshi
9 papers receiving 287 citations
Sumera Qureshi's Hit Papers
Peers
Comparison fields: 5 of 56
- Rheumatology 148
- Internal Medicine 13
- Hematology 27
- Dermatology 19
- Genetics 22
Countries citing papers authored by Sumera Qureshi
This map shows the geographic impact of Sumera Qureshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumera Qureshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumera Qureshi more than expected).
Fields of papers citing papers by Sumera Qureshi
This network shows the impact of papers produced by Sumera Qureshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumera Qureshi. The network helps show where Sumera Qureshi may publish in the future.
Co-authors
The 25 scholars most cited alongside Sumera Qureshi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 125 | |
| 2 | Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial Hit paper breakdown → | 2024 | 123 |
| 3 | 2022 | 19 | |
| 4 | An overview of available Hypoglycemic Triterpenoids and Saponins to cure Diabetes mellitus | 2014 | 12 |
| 5 | 2023 | 7 | |
| 6 | 1970 | 2 | |
| 7 | 2022 | 1 | |
| 8 | Hemoglobin adducts in paint industry workers: An electrophoretic analysis | 2014 | 1 |
| 9 | 2022 | 1 | |
| 10 | 2011 | 1 | |
| 11 | 2013 | 1 | |
| 12 | 2026 | 0 | |
| 13 | 2021 | 0 | |
| 14 | 2026 | 0 |
About Sumera Qureshi
Sumera Qureshi is a scholar working on Rheumatology, Toxicology, Marketing, Pollution and Water Science and Technology, having authored 14 papers that have together received 293 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (4 papers), COVID-19 impact on air quality (1 paper), Energy and Environment Impacts (1 paper), Forensic Toxicology and Drug Analysis (1 paper), Environmental Sustainability in Business (1 paper), Mass Spectrometry Techniques and Applications (1 paper), Water Systems and Optimization (1 paper) and Water Quality and Pollution Assessment (1 paper). The work is most often cited by research in Rheumatology (148 citations), Internal Medicine (13 citations), Hematology (27 citations), Dermatology (19 citations) and Genetics (22 citations). Sumera Qureshi has collaborated with scholars based in United Kingdom, Pakistan and India. Frequent co-authors include Sam Norton, Maryam A. Adas, Andrew P. Cope, James Benjamin Galloway, Katie Bechman, Sanketh Rampes, Mark Yates, Amir Mehrkar, Helen Jane Curtis and Colm D Andrews. Their work appears in journals such as The Lancet Rheumatology, Autoimmunity Reviews, Arthritis & Rheumatology, RMD Open and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.